NCT01721850终止不适用
Evaluation of the Safety and Efficacy of New Infant Formula and Its Effects on the Gastrointestinal Tolerance (Crying Time) in Infantile Colic: a Double-blind, Randomized, Controlled Intervention Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 169
- 试验地点
- 20
- 主要终点
- daily total crying time
研究概览
简要总结
The study is conducted to examine the safety and efficacy of a new infant formula and its effects on the gastrointestinal tolerance in infants suffering from colic.
Primary hypothesis to be tested is: an infant formula with optimized composition improves colicky symptoms compared to a standard formula.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 15 Days 至 60 Days（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy term infants
- •Subjects appropriate for gestational age between 35 and 41 weeks
- •Subjects between 15-60 days old
- •Subjects with birth weight between 2500 and 4200 g and regular weight gain (≥150g / week)
- •Diagnosis of infantile colic according to modified Wessel criteria (Crying episodes lasting 3 or more hours/day and occurring at least 3 days/week for at least 1 week)
- •Subjects exclusively bottle-fed at study entrance
- •Day care of the child only by mother/father
- •Provide written informed consent in accordance with legal requirement
排除标准
- •Neonatal problems (respiratory distress, asphyxia, Hypoglycaemia, sepsis, NEC)
- •Clinical evidence of chronic illness or gastrointestinal disorders (GER, gastroenteritis)
- •Assumption of any kind of medication (except vitamin D, vitamin K and fluoride prophylaxis) during the week before the beginning of the study and during the study period
- •Subjects receiving formula for special medical purposes
- •Exclusively breast-fed infants
- •Feeding of supplemental Pro- and/or Prebiotics two weeks prior to inclusion
- •Allergic diseases (manifest atopic dermatitis, cow's milk allergy)
- •Participation in any other clinical intervention
结局指标
主要结局
daily total crying time
时间窗: 28 days
evaluation of the difference in the average reduction of daily crying time after 28 days of intervention between treatment and control group
次要结局
- formula intake(28 days)
- growth parameters(90 days)
- tolerance evaluated by stool characteristics, gastrointestinal disorders and side effects(28 days)
- intestinal microbiota(0-28 days)
研究者
研究点 (20)
Loading locations...
相似试验
已完成
不适用
Safety and Efficacy StudyInfant Term BirthNCT02670863Société des Produits Nestlé (SPN)239
Unknown
不适用
Effect of a New Infant Formula With Specific IngredientsInfant GrowthNCT04306263Laboratorios Ordesa231
已完成
不适用
Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term InfantsInfantsNewbornNCT04218929ByHeart311
已完成
不适用
Efficacy and Safety of an Infant Formula With Milkfat and PrebioticsInfectionsStool FloraStool BiochemistryFood IntoleranceConstipationNCT01603719Waldkrankenhaus Protestant Hospital, Spandau128
已完成
不适用
To Investigate Effects of a New Infant Formula in Healthy Term Chinese InfantsHealthy InfantsNCT03520764Danone Nutricia284